0.035
0.00 (-10.26%)
| Penutupan Terdahulu | 0.039 |
| Buka | 0.040 |
| Jumlah Dagangan | 1,653,205 |
| Purata Dagangan (3B) | 863,488 |
| Modal Pasaran | 80,016,304 |
| Harga / Jualan (P/S) | 5.87 |
| Harga / Buku (P/B) | 3.68 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Feb 2025 |
| Margin Keuntungan | -183.82% |
| Margin Operasi (TTM) | -192.74% |
| EPS Cair (TTM) | -0.010 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 25.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.24% |
| Nisbah Semasa (MRQ) | 4.57 |
| Aliran Tunai Operasi (OCF TTM) | -18.29 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -14.22 M |
| Pulangan Atas Aset (ROA TTM) | -29.71% |
| Pulangan Atas Ekuiti (ROE TTM) | -50.94% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (AU) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | IMPEDIMED FPO [IPD] | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -1.0 |
| Purata | -0.75 |
|
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognises revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 9.29% |
| % Dimiliki oleh Institusi | 16.26% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |